Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-02-05
2009-10-13
Fetterolf, Brandon J (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000, C530S329000
Reexamination Certificate
active
07601693
ABSTRACT:
The present invention provides a cyclic peptide containing RRXR motif. The present invention also provides a composition comprising the said cyclic peptide and a pharmaceutical acceptable carrier. The present invention further provides a method for treating cancer.
REFERENCES:
patent: 2002/0193431 (2002-12-01), Serhan et al.
Chen et al. (Proc. American Association of Cancer Research 2006; 47: Abstract 1632).
Hong et al. (Clinical Cancer Research 2007; 13(16): 4759-4768).
Kenji Shibuya et al.; Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000; journal; Dec. 26, 2002; pp. 1-26; vol. 2, No. 37; BMC Cancer; BioMed Central Ltd.
Philip C Hoffman et al.; Lung cancer; seminar; Feb. 5, 2000; pp. 479-485; vol. 355; The Lancet.
Yok-Lam Kwong et al.; Combination Therapy With Suicide and Cytokine Genes for Hepatic Metastases of Lung Cancer; journal; Nov. 1997; pp. 1332-1337; vol. 112; Chest; The American College of Chest Physicians; Northbrook IL.
Napoleone Ferrara et al.; The biology of VEGF and its receptors; journal; Jun. 2003; pp. 669-676; vol. 9, No. 6; Nature Medicine; Nature Publishing Group.
Sergio Dias et al.; Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias; journal; Sep. 11, 2001; pp. 10857-10862; vol. 98, No. 19; PNAS.
Matilde Murga et al.; Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2; Mar. 1, 2005; pp. 1992-1995; vol. 105, No. 5; Blood; The American Society of Hematology; Washington DC.
Lee M. Ellis; The Role of Neuropilins in Cancer; Molecular Therepeutics; May 2006; pp. 1099-1107; vol. 5, No. 5; Texas.
Yi-Wen Chu et al.; Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line; American Journal, of Respiratory Cell and Molecular Biology; Nov. 4, 1996; pp. 353-360; vol. 17.
Jeremy J. Chen et al.; Profiling Expression Patterns and Isolating Differentially Expressed Genes by cDNA Microarray System with Colorimetry Detection; Genomics; Apr. 20, 1998; pp. 313-324; vol. 51, Article No. GE985354; Taiwan.
Clinton F. Mountain; Revisions in the International System for Staging Lung Cancer; Chest; 1997; pp. 1710-1717; vol. 111, No. 6; American College of Chest Physicians; Illinois.
Christian A. Heid et al.; Real Time Quantitative PCR; Genome; 1998; pp. 986-994; Cold Spring Harbor Laboratory Press; California.
Shay Soker et al.; VEGF165 Mediates Formation of Complexes Containing VEGFR-2 and Neuropilin-1 That Enhance VEGF165-Receptor Binding; Journal of Cellular Biochemistry; 2002; pp. 357-368; vol. 85; Massachusetts.
Ming-Tsan Lin et al.; Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells; The Journal of Biochemistry; 2001; pp. 48997-49002; vol. 276, No. 52; USA.
Masahito Tamura et al.; Inhibition of Cell Migration, Spreading, and Focal Adhesions by Tumor Suppressor PTEN; Journal; 1998; pp. 1614-1617; vol. 280; Science; American Advancement of Science; Washington DC.
Yuh-Ling Chen et al., Neuropilin-1 and Lung Cancer Progression: potential role of targeting neuropilin-1 as an anti-tumor strategy, poster presented at the AACR (American Association for Cancer Research) meeting in 2006, Washington DC, USA.
Chen Yuh-Ling
Hong Tse-Ming
Wu Yi-Ying
Yang Pan-Chyr
Yuan Ang
Fetterolf Brandon J
King Anthony
National Taiwan University
WPAT, P.C.
Yang Kay
LandOfFree
Composition for treating cancer and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating cancer and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating cancer and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099133